Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,719 | -29,247 | -32,813 | -24,559 | -7,837 |
| Depreciation Amortization | 2,125 | 2,023 | 1,132 | 1,130 | 984 |
| Accounts receivable | -1,720 | -246 | -1,288 | 421 | -327 |
| Other Working Capital | -4,378 | 2,649 | -3,562 | 642 | -758 |
| Other Operating Activity | 10,265 | 3,165 | 8,297 | 8,361 | 2,325 |
| Operating Cash Flow | $-14,428 | $-21,655 | $-28,234 | $-14,006 | $-5,613 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -284 | -538 | -6,087 | -3,641 | -708 |
| Purchase Sale Intangibles | -385 | -398 | -368 | -640 | -968 |
| Other Investing Activity | -385 | -398 | -368 | -640 | -968 |
| Investing Cash Flow | $-669 | $-936 | $-6,456 | $-4,281 | $-1,676 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,000 | N/A | 5,000 | 0 | 1,411 |
| Debt Repayment | -5,000 | N/A | N/A | N/A | -16,411 |
| Common Stock Issued | N/A | 218 | 0 | 805 | 1,509 |
| Other Financing Activity | -669 | 14,256 | -40 | -90 | 79,839 |
| Financing Cash Flow | $9,331 | $14,474 | $4,960 | $715 | $66,348 |
| Exchange Rate Effect | -85 | -100 | -263 | -25 | 130 |
| Beginning Cash Position | 15,615 | 23,832 | 53,825 | 71,422 | 12,232 |
| End Cash Position | 9,764 | 15,615 | 23,832 | 53,825 | 71,422 |
| Net Cash Flow | $-5,851 | $-8,217 | $-29,993 | $-17,596 | $59,189 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,428 | -21,655 | -28,234 | -14,006 | -5,613 |
| Capital Expenditure | -284 | -538 | -6,087 | -3,641 | -708 |
| Free Cash Flow | -14,712 | -22,193 | -34,322 | -17,647 | -6,322 |